ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 587,68
-0,59%
Dow Jones
40 211,72
0,53%
DAX
18 501,45
-0,53%
Brent Oil
83,71
-0,75%
Bitcoin
62 900,45
-3,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
20/02/201814h00GlobeNewswire Inc.Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. PatentNASDAQ:INSMInsmed Inc
15/02/201814h00GlobeNewswire Inc.Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018NASDAQ:INSMInsmed Inc
15/02/201800h49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
14/02/201814h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
12/02/201823h19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INSMInsmed Inc
07/02/201822h30GlobeNewswire Inc.Insmed to Present at the Leerink Partners 7th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
26/01/201818h00GlobeNewswire Inc.Insmed Announces Closing of Public OfferingNASDAQ:INSMInsmed Inc
24/01/201823h31GlobeNewswire Inc.Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
24/01/201822h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INSMInsmed Inc
24/01/201812h06Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:INSMInsmed Inc
24/01/201804h49GlobeNewswire Inc.Insmed Announces Pricing of Public Offering of Convertible Senior NotesNASDAQ:INSMInsmed Inc
22/01/201822h05Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:INSMInsmed Inc
22/01/201822h01GlobeNewswire Inc.Insmed Announces Proposed Public Offering of Convertible Senior NotesNASDAQ:INSMInsmed Inc
08/01/201822h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
03/01/201822h10GlobeNewswire Inc.Insmed Announces Additional Data from ALIS (Amikacin Liposome Inhalation Suspension) Phase 3 Clinical Program for Adult Patie...NASDAQ:INSMInsmed Inc
28/11/201714h00GlobeNewswire Inc.Insmed to Present at the Nasdaq 37th Annual Investor ConferenceNASDAQ:INSMInsmed Inc
08/11/201722h30GlobeNewswire Inc.Insmed to Present at Two November ConferencesNASDAQ:INSMInsmed Inc
08/11/201715h28Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INSMInsmed Inc
02/11/201713h00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
02/11/201712h30GlobeNewswire Inc.Insmed Reports Third Quarter 2017 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
25/10/201714h00GlobeNewswire Inc.Insmed to Host Third Quarter 2017 Financial Results Conference Call on Thursday, November 2, 2017NASDAQ:INSMInsmed Inc
19/09/201714h00GlobeNewswire Inc.Insmed to Present at Two September Investor ConferencesNASDAQ:INSMInsmed Inc
07/09/201703h37GlobeNewswire Inc.Insmed Announces Pricing of Public Offering of Common StockNASDAQ:INSMInsmed Inc
05/09/201722h01GlobeNewswire Inc.Insmed Announces Proposed Public Offering of Common StockNASDAQ:INSMInsmed Inc
05/09/201715h32Dow Jones NewsHot Stocks to Watch in the U.S. and CanadaNASDAQ:INSMInsmed Inc
05/09/201713h00GlobeNewswire Inc.Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Ad...NASDAQ:INSMInsmed Inc
03/08/201713h30GlobeNewswire Inc.Insmed Reports Second Quarter 2017 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
27/07/201714h00GlobeNewswire Inc.Insmed to Host Second Quarter 2017 Financial Results Conference Call on Thursday, August 3, 2017NASDAQ:INSMInsmed Inc
12/07/201714h00GlobeNewswire Inc.Insmed to Host Analyst and Investor Day on July 19, 2017NASDAQ:INSMInsmed Inc
13/06/201714h00GlobeNewswire Inc.Insmed to Present at the JMP Securities Life Sciences ConferenceNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

SPI
SP500
S&P 500
EU
EN
Bouygues
EU
BNP
BNP Paribas
EU
BEL20
Bel 20
EU
SGO
Cie de SaintGobain
EU
GLE
Societe Generale
EU
DG
Vinci
NYSE
JPM
JP Morgan Chase
EU
LR
Legrand
EU
RNO
Renault
EU
CAP
Capgemini
FTSE
UKX
FTSE 100
EU
CS
Axa
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés